Eric Halioua is CEO of Digital Orthopaedics and President and CEO of PDC*line Pharma. He is as well Board member of the biotechnology company Bioxodes (Belgium), VitriCell (Belgium) and Innobiochips (France). Eric is a serial entrepreneur that raised more than €90 million over the course of his career and has had numerous successes in the sale and IPO of biotechnology companies.
Eric is co-founder of four biotechnology called Myosix (bought by Genzyme mid-2002), Murigenetics, HairClone and Digital Orthopaedics. Eric worked for 12 years as a Principal Consultant in the Healthcare and Life Sciences Practice of Arthur D. Little. Eric holds two master degrees in Pharmacology and Molecular Biology and a MBA from ESSEC business school (Paris).
Eric Halioua, Co-founder & Chief Executive Officer